BioVoice News December 2017-January 2018 Issue 7 Volume 2 | Page 52

tech providers ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: Our Panoli facility is often viewed as a benchmark in the region and a benefit to the local community. Typically, it’s the case that after one multinational company has set up a quality facility in India or other emerging market, others usually have the confidence to follow. What are the new functional excipient products and laboratory products launched by Avantor in India? 52 BioVoiceNews | Dec 2017 - Jan 2018 and homogenous crystalline powders for improved control over processes, increased formulation flexibility and faster formulation development. Optimized to facilitate efficient manufacturing of immediate release drug formulations J.T.Baker brand using direct PanExcea performance compression, they can excipients were FDA be directly formulated approved in India in with all classifications 2016. These excipients of active are manufactured pharmaceutical using novel particle ingredients and engineering technology